What “Bevespi Aerosphere class” usually refers to
“Bevespi Aerosphere” is classified as a maintenance (long-term) inhaler for chronic obstructive pulmonary disease (COPD). It is taken regularly to help control symptoms and reduce exacerbations rather than to treat sudden breathing attacks.
What drug class is it in (and what’s in it)
Bevespi Aerosphere is a dual bronchodilator inhaler. It contains:
- glycopyrrolate (a long-acting muscarinic antagonist, LAMA)
- formoterol (a long-acting beta-2 agonist, LABA)
Together, those components place Bevespi Aerosphere in the LABA/LAMA class used for COPD maintenance therapy.
What condition it’s used for
This LABA/LAMA inhaler is used for COPD, including chronic bronchitis and emphysema. It’s intended for ongoing symptom management.
How it differs from rescue inhalers
Because it’s a long-acting combination (LABA/LAMA), Bevespi Aerosphere is not a rescue medicine. Rescue treatment for sudden symptoms typically uses a short-acting bronchodilator, which is a different drug class from Bevespi.
Is it a steroid or biologic class?
No. Bevespi Aerosphere is not an inhaled corticosteroid (ICS) and it is not a biologic. Its class is bronchodilators (LABA + LAMA).
Sources cited
No external sources were provided.